New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics

New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganis...

Full description

Saved in:
Bibliographic Details
Other Authors: Felgueiras, Helena (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_91188
005 20220812
003 oapen
006 m o d
007 cr|mn|---annan
008 20220812s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-4735-0 
020 |a 9783036547367 
020 |a 9783036547350 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-4735-0  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PN  |2 bicssc 
100 1 |a Felgueiras, Helena  |4 edt 
700 1 |a Felgueiras, Helena  |4 oth 
245 1 0 |a New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (232 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Chemistry  |2 bicssc 
653 |a nanoparticles 
653 |a 4-Nerolidylcatechol 
653 |a antifungals 
653 |a Microsporum canis 
653 |a polycaprolactone 
653 |a nanoprecipitation 
653 |a silver nanoparticles 
653 |a green synthesis method 
653 |a Catharanthus roseus 
653 |a Azadirachta indica 
653 |a multidrug-resistant bacteria 
653 |a wound healing 
653 |a nosocomial infection 
653 |a plant extract 
653 |a grapefruit seed extract 
653 |a antibacterial activity 
653 |a fiber-hydrogel composite 
653 |a biodegradable polymers 
653 |a skin regeneration 
653 |a drug delivery platforms 
653 |a controlled release 
653 |a tetramycin 
653 |a antimicrobial activity 
653 |a kiwifruit disease 
653 |a conventional antibiotics 
653 |a storage quality 
653 |a gold nanoparticles 
653 |a flavonoids 
653 |a Gram-negative bacteria 
653 |a DNA gyrase 
653 |a in silico 
653 |a multidrug-resistant Acinetobacter baumannii (MDR-AB) 
653 |a hypertonic saline 
653 |a antibiotics 
653 |a biofilm 
653 |a aerosol delivery 
653 |a ultrahigh-throughput screening 
653 |a live biosensors 
653 |a antibiotic discovery 
653 |a gram-negative pathogens 
653 |a microfluidic droplet cocultivation 
653 |a efficient promoters 
653 |a polymyxins 
653 |a colistin biosynthetic gene cluster 
653 |a single cell 
653 |a multi-omics 
653 |a quercetin 
653 |a magnesium-doped calcium silicate 
653 |a osteogenic activity 
653 |a bone regeneration and nanofiber scaffold 
653 |a bulk-tank milk 
653 |a mastitis 
653 |a methicillin 
653 |a milk 
653 |a goat 
653 |a somatic cell counts 
653 |a staphylococcus 
653 |a tetracycline 
653 |a total bacterial counts 
653 |a prosthetic joint infection 
653 |a local prevention 
653 |a allicin 
653 |a chitosan 
653 |a Sphaerotheca sp. 
653 |a antibiotic 
653 |a Rosa roxburghii 
653 |a cyclic diphenylphosphonate 
653 |a quinoline 
653 |a DNA gyrase inhibitor 
653 |a molecular docking 
653 |a magnesium ion 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/5834  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/91188  |7 0  |z DOAB: description of the publication